NCATS has released two funding opportunities aimed at identifying new treatments for a broad range of diseases using partially developed therapeutic candidates.
Through its Discovering New Therapeutic Uses for Existing Molecules program, NCATS helps academic researchers and pharmaceutical companies establish collaborations to test existing drugs and biologics for possible new uses.
View the web announcement for full funding details. Below are the details for the next upcoming opportunity:
Interested researchers should submit a letter of intent 30 days before the application date.